Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reversible Effects of Oral Contraceptive Removal on Serotonergic Neurotransmission

NCT07511439 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT07511439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07511439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reversible Effects of Oral Contraceptive Removal on Serotonergic Neurotransmission
Lead sponsor
Rigshospitalet, Denmark
Phase
Phase 4
Overall status
Recruiting
Start date
April 23, 2026
Completion date
December 31, 2030
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adult females, the focus of the study is to investigate reversible effects of combined oral contraceptive use on serotonergic neurotransmission